Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival

4 Nov 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Multiple Myeloma Research and Treatments
Share to Signaling Pathways in Disease

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33149265
DOI: 10.1038/s41375-020-01078-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survivalPMID 33149265Read ↗

IRF4 in multiple myeloma—Biology, disease and therapeutic targetSemantic proximity Read ↗

Bim and Bmf in tissue homeostasis and malignant diseaseSemantic proximity Read ↗

How to Reprogram Myeloma-Associated Macrophages: Target IKZF1.Semantic proximity Read ↗

Targeting NF-κB Signaling for Multiple MyelomaSemantic proximity Read ↗

The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myelomaSemantic proximity Read ↗

The BMP pathway: A unique tool to decode the origin and progression of leukemiaSemantic proximity Read ↗

Impact of hypoxia on the pathogenesis and therapy resistance in multiple myelomaSemantic proximity Read ↗

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myelomaSemantic proximity Read ↗

WITHDRAWN: Canonical NF-κB regulator CYLD mutations reinforce RelB mediated disease pathogenesis in Multiple MyelomaSemantic proximity Read ↗

The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma PathophysiologySemantic proximity Read ↗

ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple MyelomaSemantic proximity Read ↗

c‐FOS is an integral component of the IKZF1 transactivator complex and mediates lenalidomide resistance in multiple myelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.